secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tengjun Biotechnology Corp. (—)
CIK:        0001499785
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001213900-23-067084
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tengjun Biotechnology restates FY2022 financials, appoints new CEO/CFO after prior officer's death
--------------------------------------------------------------------------------

- Board determined FY2022 financial statements unreliable due to accounting errors; restatement via amended 10-K planned.
- Previous Director, CEO, and CFO Xianchang Ma passed away on August 3, 2023.
- Ms. Caihong Qu appointed as Director, interim CEO, and CFO effective August 10, 2023.
- Ms. Qu (age 48) is the late wife of Mr. Ma and legal rep of Jinxiang County Kanglong Water Purification Equipment Co., Ltd.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1499785/000121390023067084/0001213900-23-067084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1499785/000121390023067084/ea183436-8k_tengjun.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-067084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer